Together, we believe our novel findings through the use of CD40KO mice and a CD40 blocking peptide in WT mice elucidate the important role of CD40 in MC-LR exacerbation of colitis and its potential as a therapeutic target in populations with pre-existing that are more vulnerable and susceptible to MC-LR toxicity. The gene discussed is CD40; the disease is colitis.